* V0 @ 1.5 and 3.0mm FR PC/ABS failed 0% 20% 40% 60% 80% 100% 120% 140% Virex TB Clorox Broad Spectrum CaviCide SaniCloth Plus wipes 1% strain not tested 1% strain not tested FR PC/ABS failed FR PC/ABS failed FR PC/ABS failed FR PC / ABS (1.0% Strain) FR PC / ABS (1.5% Strain) Trilliant HC (1.0% strain) Trilliant HC (1.5% strain) FR PC/ABS failed 0% 20% 40% 60% 80% 100% 120% 140% Virex TB Clorox Broad Spectrum CaviCide SaniCloth Plus wipes 1% strain not tested 1% strain not tested FR PC/ABS failed FR PC/ABS failed FR PC/ABS failed FR PC / ABS (1.0% Strain) FR PC / ABS (1.5% Strain) Trilliant HC (1.0% strain) Trilliant HC (1.5% strain) TENSILE STRENGTH RETENTION AFTER 7 DAYS EXPOSURE Both materials were tested according to ASTM D543 for 7 days.

Customers received genuine product backed by the reputation of the manufacturer, not some pirate. © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012

Forward‐looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales. • Factors that could cause actual results to differ materially from those implied by these forward looking statements include but are not limited to:• Factors that could cause actual results to differ materially from those implied by these forward‐looking statements include, but are not limited to:  Our ability to achieve the strategic and other objectives relating to the Spartech acquisition, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;g p y p g ;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;, , p y p y g , y p p ;  An inability to maintain appropriate relations with unions and employees; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. • The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.

Figure 1 shows the TEM of two of SEBS/oil/PP compound (1). Reference 1. TMA strain versus temperature measurement -2000 -1500 -1000 -500 0 D im en si on C ha ng e (µ m ) 20 40 60 80 100 120 140 160 180 200 Temperature (°C) ––––––– 224-020A-10N-HDT.003 – – – – 224-001A-HDT Universal V2.6D TA Instruments 3038 / ANTEC 2003 Figure 3.

Avient Climate-related Scenario Analysis Summary SCOPE & TIME HORIZON AVIENT SCENARIO NET ZERO FUTURE PLEDGING PROGRESS STEADFAST POLICY CONVENTION 1.3-1.5°C 1.9-2.3°C 2.4-2.8°C TRANSITION RISK Net Zero Emissions Scenario Announced Pledges Scenario Stated Policies Scenario (IEA WEO 2021 1 scenarios) (NZE) | 1.4°C (APS) | 2.1°C (STEPS) | 2.6°C Emissions peak at 2050 and slowly decline through 2100 Emissions continue to rise beyond 2100 at slower rates Emissions continue to rise beyond 2100 at current rates BUSINESS IMPLICATIONS Increased transition risk: Business impacted by climate policies, carbon prices, market pressures and technological advancements Increased physical risk: Business impacted by direct damages and indirect discruption assocated with severe changes in climate driven weather events · Highly regulated policy environment · Moderate policy regulation · Few changes to current policy settings · Ambitious; net zero commitments achieved at most all levels · Government commitments and National Determined Contributions are achieved · Not all stated commitments are achieved · Improved air pollution in advanced and emerging market & developing economies · Rising air pollution levels especially in emerging market and developing economies · Doubling of the frequency of extreme heat events by 2050 and 120% increase in intensity & rising air pollution levels especially in emerging market and developing economies · Expectation of signifcant capital allocation for innovative product design, energy efficiency investments, and clean electrification of operations · Additional levels of R&D investment will be required to contribute to and attain announced commitments. · Continued R&D investment in current initiatives is expected · Steep increases in advanced economies' carbon prices · Considerable increases in emerging economies' carbon prices · Some change in carbon prices · Declining fuel prices · Regional variability in fuel prices, though slight net increase · Rising fuel prices 1 International Energy Agency World Energy Outlook 2021 The following summarizes Avient's climate-related risks and opportunities analyzed across multiple scenarios, in alignment with the Task Force on Climate-Related Financial Disclosures (TCFD) framework. ADAPTATION & STRATEGIC CONSIDERATIONS ADAPTATION & STRATEGIC CONSIDERATIONS · Avient's Environmental and Product Stewardship Polices set a foundation for greater operational and external policy expectations aligned with energy efficiency standards, renewable energy procurement, supplier engagement (i.e., Media & Stakeholder Analyses {MSA} climate criteria) · The current and future focus is on continued Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) assessments, reclassifications and communication on the safe use and handling of these substances. Clean electrification of our operations and processes will represent some of our current scope 1 emissions reductions, though further evaluation is required. · Avient became a member of the RE100 initiative in 2021, committing to achieving 60% renewable energy use by 2030.

Specifically, here are five ways TPEs can help the healthcare industry meet an anticipated capacity crunch: 1. Parts Cost Surplus Stock Carbon Footprint Power Consumption Production Time TPE Benefits TPEs can reduce: TPE Applications TPEs can used to produce: Better grips on instruments Easy branding Easy-to-open pill bottles Needs to Meet Future Growth 2010 TPE Substrate 2030 Future Demand 2050 Supply Chain Capacity TPE Substrate Parts Cost Surplus Stock Carbon Footprint Power Consumption Production Time TPE Benefits TPEs can reduce: TPE Applications TPEs can used to produce: Better grips on instruments Easy branding Easy-to-open pill bottles Needs to Meet Future Growth 2010 TPE Substrate 2030 Future Demand 2050 Supply Chain Capacity TPE Substrate 3© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 3. Pharmaceutical and medical device companies like yours are looking for new strategies to improve operational efficiencies so you can meet current requirements and scale up for the future.

Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They use words such as “will,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

GAAP EPS includes $0.35 of special items (see Attachment 3) and $0.16 of intangible amortization expense (see Attachment 1). Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

The company noted that first quarter 2024 GAAP EPS includes $0.06 of special items (see Attachment 3) and $0.16 of intangible amortization expense (see Attachment 1). Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. Use of Non-GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Strategy and Execution Drive Results Page 4 All time closing high of $29.48 August 1, 2013 • 15 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 42% versus 20% growth in the S&P • 275% increase in market cap: $0.7b $2.6b since 2006 The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target Ad ju st ed E ar ni ng s P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 6 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items **Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations 2% 34% 43% 45% 60% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2012 2012 PF** 2015 % o f O pe ra tin g In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $114M $150M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 H1 2013 2015 Where we were Where we are Organic Consolidated Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.7% 12.6% 12 – 16% Global Specialty Engineered Materials 1.1% 10.9% 9.2% 12 – 16% Designed Structures & Solutions — — 4.4% 8 – 10% Performance Products & Solutions 5.4% 8.1% 8.2% 9 – 12% Distribution 2.6% 6.1% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 26% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 46.5% 2006 Q2 2013 $20.3 $44.7 2006 TTM Q2'13 14.3% 31.1% 2006 Q2 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 9 We are Experts in Polymer Science and Formulation  Polymer Science  Formulation  Chemistry  Processing Inputs  Base Resins  Additives  Modifiers  Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services  Marketplace Demands  Performance Requirements  Value Drivers Page 10 Positioned for Strong Growth 2015 Target Rev: $5B Adj. Senior management uses adjusted operating income, adjusted EPS, and working capital to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and that current levels may serve as a base for future performance.